Jazz Pharmaceuticals (JAZZ) Finished Goods (2010 - 2019)

Jazz Pharmaceuticals' Finished Goods history runs 10 years deep, the most recent figure standing at $22.3 million for Q1 2019.

• On a quarterly basis, Finished Goods changed N/A year-over-year to $22.3 million in Q1 2019; TTM through Mar 2019 was $22.3 million, a N/A change from a year earlier, with the FY2018 full-year figure at $21.3 million, down 11.22% from the prior year.
• Finished Goods grew to $22.3 million in Q1 2019 per JAZZ's latest filing, from $21.3 million in the prior quarter.
• Across five years, Finished Goods topped out at $24.0 million in Q4 2017 and bottomed at $5.0 million in Q4 2015.
• The 5-year median for Finished Goods is $17.9 million (2018), against an average of $16.0 million.
• Across the five-year window, Finished Goods slumped 69.83% in 2015 and surged 175.91% in 2016, its largest moves.
• Year by year, Finished Goods stood at $5.0 million in 2015, then jumped by 175.91% to $13.8 million in 2016, then surged by 73.8% to $24.0 million in 2017, then dropped by 11.22% to $21.3 million in 2018, then rose by 4.68% to $22.3 million in 2019.
• Per Business Quant, the three latest JAZZ Finished Goods figures stand at $22.3 million (Q1 2019), $21.3 million (Q4 2018), and $17.9 million (Q2 2018).